Will NVIDIA Be Knocked Off Its Perch By Quantum?
Earlier this month, NVIDIA CEO Jensen Huang seemingly dashed the hopes of speculative tech investors banking on quantum computing to become the next big thing in the ever-advancing race for faster and faster computer processing. Huang, speaking at the Consumer Electronics Show, stated his view that practical quantum computers were still about two decades away, causing a selloff among the stocks of quantum startups. » Read more about: Will NVIDIA Be Knocked Off Its Perch By Quantum? »
Read More
Market Commentary: 1 Brazilian Fintech Buffett Bought In Spades
The rise of financial technology (fintech) in Brazil has been a major force for change in the country’s economy. Driven by technological innovation and fierce market demand, fintech has made financial services more accessible and efficient for millions of Brazilians.
Read More
Market Commentary: Little-Known Indicator Forecasts Market Plunge
Some indicators aren’t well known or understood but can be highly effective when used by proficient traders. SKEW is one such indicator; it measures the perceived tail risk of the distribution of S&P 500 investment returns over a 30-day horizon.
Read More
Market Commentary: When To Sell Your Stock, Precisely
Buying stocks is easy but when should you sell them? Today we’ll take a look at a specific example of precisely when to take profits, and move to the next best trading idea.
We’re going to use Upstart for our case study. In the chart below, you can see Upstart was in a a bullish trend since early May.
» Read more about: Market Commentary: When To Sell Your Stock, Precisely »
Read More
Billionaire Buys Stake In Gene Therapy Stock
Ultragenyx may not have crossed your radar but it’s already in billionaire Stan Druckenmiller’s portfolio. What has he spotted in this novel therapies for rare and ultra-rare genetic diseases firm that convinced him to take a position?
Its focus on underserved patient populations, deep pipeline of innovative products, and strong track record in obtaining regulatory approvals make it an attractive long-term investment,
» Read more about: Billionaire Buys Stake In Gene Therapy Stock »
Read MoreThe Ivy
2 Stocks Set To 2x In 24 Months
It’s been a volatile stretch for the markets. Between trade tensions, economic jitters, and mixed signals from policymakers, investors have had no shortage of reasons to stay on edge. The S&P 500 has slipped into correction territory, down more than 10% from its highs thanks in part to uncertainty over tariffs and recession fears.
But for seasoned investors,
» Read more about: 2 Stocks Set To 2x In 24 Months »
Read MoreThe Spotlight
1 Royal ETF To Buy Without Hesitation
Five years ago when I last visited Saudi Arabia, the kingdom closely resembled the image many westerners might imagine.
First, it was challenging just to figure out how to get a visa. The answer lay in a dark room in a difficult-to-access New York building. Upon arrival, there was no such thing as socializing with women.
» Read more about: 1 Royal ETF To Buy Without Hesitation »
Read MoreThe Daily
US Stock Market Today: Dow Jones, S&P 500 Edge Higher As Trump Tempers China Stance
The Wall Street opened higher on Monday, after US President Donald Trump said trade relations with China “will all be fine”. Minutes into the trade, the Dow Jones Industrial Average rose 380.88 points or 0.84%, S&P 500 also rose over 1.17%, and Nasdaq was up 1.79%.
US stocks fell on Friday after Trump’s threat of higher tariffs on China.